IntraCellular Therapies (ITCI)
(Delayed Data from NSDQ)
$80.39 USD
-0.45 (-0.56%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $80.43 +0.04 (0.05%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/07/2024
Time: BMO |
6/2024 | $-0.18 | 0.52% |
Earnings Summary
For their last quarter, IntraCellular Therapies (ITCI) reported earnings of -$0.16 per share, beating the Zacks Consensus Estimate of $-0.31 per share. This reflects a positive earnings surprise of 48.39%. Look out for ITCI's next earnings release on August 07, 2024. For the next earning release, we expect the company to report earnings of -$0.18 per share, reflecting a year-over-year increase of 60%.
Earnings History
Price & Consensus
Zacks News for ITCI
Should You Invest in the SPDR S&P Pharmaceuticals ETF (XPH)?
ITCI: What are Zacks experts saying now?
Zacks Private Portfolio Services